Literature DB >> 33466596

The Full Region of N-Terminal in Polymerase of IBDV Plays an Important Role in Viral Replication and Pathogenicity: Either Partial Region or Single Amino Acid V4I Substitution Does Not Completely Lead to the Virus Attenuation to Three-Yellow Chickens.

Weiwei Wang1, Yu Huang1, Zhonghua Ji1, Guo Chen1, Yan Zhang1, Yuanzheng Qiao1, Mengya Shi1, Min Li1, Teng Huang1, Tianchao Wei1, Meilan Mo1, Xiumiao He2,3, Ping Wei1.   

Abstract

Infectious Bursal Disease Virus (IBDV) has haunted the poultry industry with severe, prolonged immunosuppression of chickens when infected at an early age and can easily lead to other secondary infections. Understanding the pathogenic mechanisms could lead to effective prevention and control of Infectious Bursal Disease (IBD). Evidence suggests that the N-terminal domain of polymerase in segment B plays an important role, but it is not clear which part or residual is crucial for the pathogenicity. Using a reverse genetics technique, a molecular clone (rNN1172) of the parental vvIBDV strain NN1172 was generated, and its pathogenicity was found to be the same as the parental virus. Then, three recombinant chimeric viruses were rescued based on the rNN1172 and substituted with the counterparts in the N-terminal domain of the attenuated vaccine strain B87: the rNN1172-B87VP1a (substituting the full region of the 1-167 aa residuals), the rNN1172-B87VP1a∆4 (substituting the region of the 5-167 aa residuals), and the rNN1172-VP1∆4 (one single aa residual substitution V4I), to better explore the role of the N-terminal domain of polymerase on the viral pathogenicity. Interestingly, all these substitutions played different roles in the viral pathogenicity: the mortality of the rNN1172-B87VP1a-challenged chickens was significantly reduced from 30% to 0%. No obvious lesion was found in the histopathological examination, and the lowest viral genome copy number was also detected in the bursa when compared to the parental and two other recombinant viruses. The mortalities caused by rNN1172-B87VP1a∆4 and rNN1172-B87VP1∆4, respectively, were all reduced to 10% and had a delayed onset of death. Our results also revealed that the pathogenicity of the IBDV was consistent with the viral replication efficiency in vivo (bursae). This study demonstrated that the full region of the N-terminal of polymerase plays an important role in viral replication and pathogenicity, but the substitutions of its partial region or a single residual do not completely lead to the virus attenuation to Three-Yellow chickens, although that significantly reduces its pathogenicity.

Entities:  

Keywords:  Infectious Bursal Disease Virus; N-terminal domain of VP1; recombinant virus; reverse genetics technique; viral replication and pathogenicity

Year:  2021        PMID: 33466596      PMCID: PMC7828667          DOI: 10.3390/v13010107

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  65 in total

1.  Serological study reveal different antigenic IBDV strains prevalent in southern China during the years 2000-2017 and also the antigenic differences between the field strains and the commonly used vaccine strains.

Authors:  Xiumiao He; Weiwei Wang; Guo Chen; Pengtao Jiao; Zhonghua Ji; Lin Yang; Ping Wei
Journal:  Vet Microbiol       Date:  2019-10-17       Impact factor: 3.293

2.  The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus.

Authors:  D Schnitzler; F Bernstein; H Müller; H Becht
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

3.  Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus.

Authors:  M Brandt; K Yao; M Liu; R A Heckert; V N Vakharia
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Genetic reassortment of infectious bursal disease virus in nature.

Authors:  Yongwei Wei; Jianrong Li; Jiangtao Zheng; Hong Xu; Long Li; Lian Yu
Journal:  Biochem Biophys Res Commun       Date:  2006-09-20       Impact factor: 3.575

5.  Molecular epidemiology studies on partial sequences of both genome segments reveal that reassortant infectious bursal disease viruses were dominantly prevalent in southern China during 2000-2012.

Authors:  Xiumiao He; Zhongxian Xiong; Lin Yang; Dingming Guan; Xiuying Yang; Ping Wei
Journal:  Arch Virol       Date:  2014-08-31       Impact factor: 2.574

6.  An improved method for infectious bursal disease virus rescue using RNA polymerase II system.

Authors:  Xiaole Qi; Yulong Gao; Honglei Gao; Xiaoyun Deng; Zhigao Bu; Xiaoyan Wang; Chaoyang Fu; Xiaomei Wang
Journal:  J Virol Methods       Date:  2007-03-23       Impact factor: 2.014

7.  Tissue culture infectivity of different strains of infectious bursal disease virus is determined by distinct amino acids in VP2.

Authors:  Egbert Mundt
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

8.  A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens.

Authors:  K J Fahey; K Erny; J Crooks
Journal:  J Gen Virol       Date:  1989-06       Impact factor: 3.891

9.  Generation of a mutant infectious bursal disease virus that does not cause bursal lesions.

Authors:  K Yao; M A Goodwin; V N Vakharia
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

10.  The VP5 protein of infectious bursal disease virus promotes virion release from infected cells and is not involved in cell death.

Authors:  Yongping Wu; Lianlian Hong; Juxiu Ye; Zhenyu Huang; Jiyong Zhou
Journal:  Arch Virol       Date:  2009-10-20       Impact factor: 2.574

View more
  2 in total

1.  From nasal to basal: single-cell sequencing of the bursa of Fabricius highlights the IBDV infection mechanism in chickens.

Authors:  Abid Ullah Shah; Yuchen Li; Wei Ouyang; Zhisheng Wang; Jinjiao Zuo; Song Shi; Qinghua Yu; Jian Lin; Qian Yang
Journal:  Cell Biosci       Date:  2021-12-16       Impact factor: 7.133

2.  Blood B Cell Depletion Reflects Immunosuppression Induced by Live-Attenuated Infectious Bursal Disease Vaccines.

Authors:  Céline Courtillon; Chantal Allée; Michel Amelot; Alassane Keita; Stéphanie Bougeard; Sonja Härtle; Jean-Claude Rouby; Nicolas Eterradossi; Sebastien Mathieu Soubies
Journal:  Front Vet Sci       Date:  2022-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.